Related Experiment Video

Updated: Jul 10, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

[Inhibition of activator protein 4 gene expression by RNA interference in human colon carcinoma cell line SW480]

Jie Cao1, Ming-Hua Tan, Hui Wang

  • 1Department of Gastrointestinal Surgery, The First Municipal People's Hospital of Guangzhou, Guangzhou Medical College, Guangzhou, China. czhongt@126.com

Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
|November 15, 2007
PubMed
Abstract

Insights

Silencing the activator protein 4 (AP-4) gene using siRNA effectively inhibits human colon cancer cell growth and invasion. This approach also significantly increases cancer cell apoptosis, offering a potential new therapeutic strategy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Silencing

Context:

  • Colon carcinoma is a significant global health concern.
  • Activator protein 4 (AP-4) plays a role in cancer progression.
  • Targeting specific genes offers novel therapeutic avenues.

Purpose:

  • To construct and validate an siRNA expression plasmid targeting the AP-4 gene.
  • To investigate the effects of AP-4 gene silencing on human colon carcinoma SW480 cells.
  • To assess the impact on cell proliferation, apoptosis, cell cycle, and invasion.

Summary:

  • AP-4 gene silencing was achieved via siRNA transfection in SW480 cells, reducing AP-4 mRNA by 57.8% and protein by 75.2%.
  • This resulted in significant inhibition of cell growth (61%-78%), increased apoptosis (21.7% vs. 2.31%), and cell cycle arrest in G0-G1 phase.
  • Furthermore, AP-4 siRNA significantly reduced SW480 cell invasion through matrigel.

Impact:

  • AP-4 gene silencing demonstrates potent anti-cancer effects in vitro.
  • This study validates siRNA technology as a viable method for targeting AP-4 in colon cancer.
  • The findings suggest AP-4 siRNA as a promising therapeutic candidate for human colon cancer treatment.

More Related Videos

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells10:34

Using an Automated Cell Counter to Simplify Gene Expression Studies: siRNA Knockdown of IL-4 Dependent Gene Expression in Namalwa Cells

Published on: April 14, 2010

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...